Table 2: Baseline characteristics of

the study population. (N = 275).

Characteristics

Experimental group

Sex

Men

150

Woman

125

Age (years)

56 ± 10

LVEF, (%)

40 ± 4.8

Size, (m)

1.63 ± 14

Weight, (kg)

84 ± 10.7

BMI

34 ± 3.1

Abdominal circumference, (cm)

93 ± 7.5

Fat*

29 ± 4.4

Muscle*

32 ± 9.1

Force, (kg)

27 ± 9.3

Sarcopenia*

32%

Calf circumference

37.9 ± 11.5

Cholesterol, (mg/dL)

195 ± 13.5

Triglycerides, (mg/dL)

130 ± 12.7

LDL, (mg/dL)

118 ± 23.4

HDL, (mg/dL)

41 ± 3.6

Fasting glucose, (mg/dL)

135 ± 11.3

Estimated VO2

7.5 ± 5.7

METs

2.1 ± 1.6

Fatigue (FACT-F)

16.3 ± 9.7

Quality of life

108 ± 14.0

Distance traveled

243 ± 23.0

MHR in stress test

156 ± 12.0

Overweight and/or obesity*

78

Abdominal obesity*

88

Dyslipidemia*

25

Arterial hypertension*

31

Diabetes mellitus*

56

Renal disease*

11

Sedentary lifestyle*,‡

91

Depression*

57

Anxiety*

18

Smoking*

40

Alcoholism*

15

Improper diet*

56

MI history*

4

Sex female*

45

Age,*

5

FACT-F = functional assessment of cancer therapy fatigue.

mg/dL = milligrams/deciliters.

METs = metabolic equivalent.

MHR = maximum heart rate.

* Percentage.

Less than 150 minutes per week.

§ Over 60 years old.